Ibat inhibitors for the treatment of liver diseases
AssigneeAlbireo AB
InventorsPer-Göran Gillberg, Hans Graffner, Ingemar Starke
Life of this patent
Estimating the term…
Abstract
The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
Claims22
(canceled)
A method for treating primary biliary cirrhosis (PBC) comprising orally administering to a subject in need of such treatment a therapeutically effective amount of an IBAT inhibitor, or a pharmaceutically acceptable salt thereof, and ursodeoxycholic acid.
A method for treating a liver disease selected from the group consisting of primary biliary cirrhosis (PBC);
- Alagille syndrome (ALGS);
- primary sclerosing cholangitis (PSC);
- and progressive familial intrahepatic cholestasis (PFIC), the method comprising orally administering to a subject in need of such treatment a therapeutically effective amount of an IBAT inhibitor, or a pharmaceutically acceptable salt thereof, and ursodeoxycholic acid.
22-24. (canceled)
Dependencies are inferred from the claim text.